WellO2 makes breathing easier

Recent news, articles & releases

WellO2, innovation developed by the Finnish company WellO2 Oy (formerly known as Hapella Oy), is a breathing exercise device that strengthens and cleanses the lungs. The mission of the company is to promote the respiratory health of, for example, elderly, athletes, singers and people with different kinds of respiratory problems.


The internationally patented technology of WellO2 breathing exercise device combines counter pressure exhaling and inhaling and steam breathing. The adjustable steam temperature and breathing resistance provide optimal conditions for respiratory training with the device, regardless of the user's condition.


”The device can be used daily for maintaining the condition of breathing muscles and airways”, tells Tuomas Mattelmäki, CEO at WellO2.


“When using the device, the user first adds water to the device and adjusts the appropriate resistance as well as steam temperature. Inhalations and exhalations are repeated 10 to 15 times so that the user empties the lungs with steady exhalation to the device and after that inhales warm steam that the device has generated”, he continues.


The device helps to open airways, cleanses lungs effectively by removing mucus and air particles and improves performance by strengthening respiratory muscle power and endurance. A double body structure and protection valves in breathing regulator protect the user from exposure to hot water.


“In addition to safety and ease-of-use, the device is easy to maintain as well; it has a built-in sanitation program that allows parts of the device to be deep cleaned using hot steam”, Mattelmäki tells.


WellO2 officially cooperates with the Finnish Organisation of Respiratory Health and Finnish Paralympic Committee. Already more than 40,000 units have been sold and the user experience has been very positive.


Added value by co-creation


WellO2, which has started to further develop their breathing exercise device, chose Innokas Medical as their partner for the product development project launched in the spring of this year.


”In this project, together with Innokas Medical’s Design Studio team, we’re developing a breathing measuring device that will be connected to our WellO2 device”, Mattelmäki tells.


“This new measuring device will be connected with mobile application that will be developed during this project as well. It will provide, for example, real-time information on the condition of the respiratory health of patients”, he continues.


Mikko Kangas, working as Business Development Director at Innokas Medical, is very happy that Innokas’ wide range competence pool perfectly matches WellO2’s needs to co-create this innovation to the market.


”There are wide range of specialists in the project from Innokas’ Design Studio team; industrial designer, mechanical and electrical engineers, embedded and mobile software designers, project manager and user interface as well as usability engineers. We’re also utilizing our quality and regulatory specialists in the project always when needed”, Kangas tells.


Mattelmäki says that the cooperation between WellO2 and Innokas Medical has started well. He sees that Innokas will be able to create significant added value for WellO2 through the company’s long-term design and development experience.


“Especially Innokas Medical’s agile development process, wide-ranging competence pool and references in implementing similar type of design projects were key factors when choosing a partner,” Mattelmäki says and continues:


“We also feel that through this cooperation and Innokas Medical’s strong expertise, our own understanding of carrying out a product development project like this will increase significantly. As a whole, it can be said that cooperation with Innokas creates us clear added value.”


For more information, please contact:

Tuomas Mattelmäki, CEO, WellO2 Oy: tuomas.mattelmaki@wello2.com

Mikko Kangas, Business Development Director, Innokas Medical Ltd.: mikko.kangas@innokasmedical.fi


For more information about WellO2, please go to: